Pulse Biosciences enters $75M at-the-market equity distribution agreement with Mizuho

PULSE BIOSCIENCES, INC.

Aggregate offering price of up to $75M of common stock via ATM facility.
Mizuho Securities USA LLC acts as sales agent; commission up to 3.0% of gross proceeds.
Sales may be made on Nasdaq or in negotiated transactions at prevailing market prices.
Company is not obligated to sell any shares and may suspend offerings at any time.
Prospectus supplement filed August 6, 2026 under existing S-3 registration statement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.